Zacks Small Cap Research – CTSO: CytoSorbents Announces Rights Offering Which has the Potential to Substantially Increase Available Liquidity – Go Health Pro
By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On December 9, 2024, CytoSorbents (NASDAQ:CTSO) announced a shareholder friendly anticipated Rights Offering which is expected to substantially increase its liquidity position. Investors who own or have bought CTSO stock by the close of trading on Friday, December 13, 2024 will be considered stockholders … Read more
